AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Dimensional and Developmental Profiles of Psychosis in Children and Adolescents

RecruitingNAAges 7 Years - 20 YearsAllAssistance Publique - Hôpitaux de Paris
💬

In plain words

What the trial is, and whether it could suit you

Five collaborating sites in France will study the broad spectrum of schizophrenia in children and adolescents. Patients will be studied with diagnostic interviews, developmental histories, dimensional clinical ratings, comprehensive cognitive assessments, neuroimaging and DNA (copy number variant) analyses (in families and patients who agree), and follow-up of course of illness, cognitive status and treatment response to specific antipsychotic drugs. The goal of the study is to test a prior hypothesis about clinical subgroups in this population and to test whether these subgroups predict antipsychotic medication response.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria for the Patient: 1. Children and young adults ages 7-20 years with age of onset of psychotic disorder between 7-17 years. 2. Hospitalized or seen for out-patient treatment for a psychotic episode, acute or chronic. 3. DSM-V diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, psychotic disorder not otherwise specified, or major depressive episode with psychotic features. 4. Written informed consent signed by the parents or the individual(s) with legal parental authority, and by the minor patient if his/her condition permits. 5. Written informed consent signed by the patient if he/she is a major, after clinical stabilization (not delusional). 6. Has health insurance coverage from Social Security (France) (not AME coverage). Inclusion Criteria for parents or siblings wishing to participate in the genetic part of the study : 1. Parents : no specific criteria. 2. Siblings : siblings are eligible to participate if there are at least two first-degree relatives with psychotic disorders (including the patient) in the family. 3. Written informed consent for the genetic part of the study signed by any participating parents and siblings. 4. Has health insurance coverage from Social Security (France) (not AME coverage). Exclusion Criteria: 1. Moderate or severe intellectual deficiency (IQ \< 50). 2. Psychoses judged to be secondary to medical illness, medication effects or drugs of abuse. 3. Diagnosis of bipolar disorder. 4. Patients who are under legal guardianship. 5. For the neuroimaging part of the study only : any contraindications to Magnetic Resonance Imaging.
💊

What it tests

  • clinical, neuroimaging and DNA assessments
📍

Where

6 sites
Fondation Vallée, Gentilly
Gentilly, France
CHRU de Lille
Lille, France
CHU de Nice
Nice, France
Pitié Salpétrière
Paris, France
CHU de Rouen
Rouen, France
CHU de Rouvray
Rouen, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy